AstraZeneca | Results Presentation Deck | 45 slides

AstraZeneca · 2023-02
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

45
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
Includes Q4 performance metrics and 2023 guidance.summarize
Open slide detailBeat · NeedLoop · Logic Chain
06
The slide uses a 2x2 grid for metrics and a list for pipeline examples.summarize
Open slide detailBeat · NeedLoop · Logic Chain
07
The slide uses a two-column layout: one for R&D platform categories and one for quantitative output metrics.summarize
Open slide detailBeat · NeedLoop · Logic Chain
08
The slide uses a split-view layout comparing current year (2023) performance with long-term strategic goals.summarize
Open slide detailBeat · NeedLoop · Logic Chain
09
transition
Open slide detailBeat · SatisfactionLoop · Logic Chain
10
The slide uses a standard financial reporting format for core profit and loss, highlighting constant exchange rate (CER) changes.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
11
Includes CER (constant exchange rate) changes and percentage of total revenue metrics.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
12
The slide uses a waterfall bridge to explain the movement in net debt, highlighting CFO, Capex, deal payments, and dividends.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
13
Slide 13 of a presentation deck.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
14
transition
Open slide detailBeat · SatisfactionLoop · Logic Chain
15
CER = constant exchange rates; ERoW = Established Rest of World.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
16
The slide uses a navigation bar at the top to indicate the current section (Oncology).summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
17
Includes a Kaplan-Meier survival curve and a study design flow chart.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
18
The slide uses a split-panel layout to compare two different drug programs, each supported by clinical trial data (Kaplan-Meier curves and waterfall plots).summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
19
Includes a visual representation of antibody-drug conjugate mechanism on the left.present_solution
Open slide detailBeat · SatisfactionLoop · Logic Chain
20
The slide uses a comparison layout to detail two distinct drug development programs.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
21
introduce_nominees
22
The slide uses a navigation bar at the top to indicate the current section (BioPharmaceuticals).analyze_data
23
Slide uses a grid layout to present product-specific commercial updates.summarize
24
The slide uses a column-based layout to organize drug development programs. 'NEW' tags highlight recent additions or updates.summarize
25
The slide uses a three-column layout to present clinical data for three distinct drug combinations.analyze_data
26
Includes a trial design diagram for tozorakimab and indication expansion status for Saphnelo.summarize
27
The slide features a portrait of the CEO and a scientific illustration of antibodies/proteins.introduce_nominees
28
Includes a stacked bar chart showing revenue by product (Ultomiris, Soliris, Strensiq, Other) over 2021-2022 quarters.analyze_data
29
Includes clinical trial data references and regulatory status for danicopan.summarize
30
The slide uses a two-column layout to contrast two distinct R&D programs.present_solution
31
summarize
Open slide detailBeat · Action
32
The slide uses a two-column layout to contrast short-term pipeline milestones with long-term strategic growth pillars.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
33
The slide features a grid of 9 executives with their names and titles.introduce_nominees
Open slide detailBeat · Action
35
The slide uses color coding to distinguish between Oncology (maroon), BioPharmaceuticals (teal), and Rare Disease (not explicitly shown in the legend but impliesummarize
36
The slide uses a dot chart to show historical ratings and a list-based scorecard for qualitative ESG performance.analyze_data
37
Includes a stacked bar chart for quarterly revenue and a pie chart for Q4 2022 regional revenue distribution.analyze_data
38
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
39
The slide contains two stacked bar charts with corresponding data tables below them.analyze_data
40
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
41
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
42
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
43
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
44
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data